PROfortil  is the only formulation that has eight clinical studies^1-5 demonstrating its efficacy and safety.

In a controlled study of 205 patients¹, for example, PROfortil was superior to the control group in improving all key metrics for sperm quality – ejaculatory volume, cell density, motility and morphology.

More importantly, after three months of treatment with PROfortil 26% of couples achieved pregnancy.

In a separate study², PROfortil was given to male patients with subclinical varicocele. Post-treatment evaluation showed an improvement in all male fertility parameters, with pregnancy occurring in 41% of couples.

PROfortil is made in Austria with European-sourced ingredients and produced in compliance with Pharmaceutical Good Manufacturing Practices.